Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02436187
Other study ID # PG/13/81/30474
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2003
Est. completion date June 2013

Study information

Verified date June 2019
Source University of Leeds
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The aim of the study is to quantify the excess mortality associated with non-adherence to care for non ST-elevation myocardial infarction in England and Wales over the last decade.


Recruitment information / eligibility

Status Completed
Enrollment 389057
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- aged 18 years or more

- patients hospitalised with non ST-elevation myocardial infarction

Exclusion Criteria:

- patients hospitalised with phenotypes other than non ST-elevation myocardial infarction

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom University of Leeds Leeds

Sponsors (1)

Lead Sponsor Collaborator
University of Leeds

Country where clinical trial is conducted

United Kingdom, 

References & Publications (2)

Dondo TB, Hall M, Timmis AD, Gilthorpe MS, Alabas OA, Batin PD, Deanfield JE, Hemingway H, Gale CP. Excess mortality and guideline-indicated care following non-ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017 Aug;6(5):412-420. doi: 10.1177/2048872616647705. Epub 2016 May 3. — View Citation

Dondo TB, Hall M, Timmis AD, Yan AT, Batin PD, Oliver G, Alabas OA, Norman P, Deanfield JE, Bloor K, Hemingway H, Gale CP. Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study. BMJ Open. 2016 Jul 12;6(7):e011600. doi: 10.1136/bmjopen-2016-011600. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality Participants will be followed up for an expected average of 8 years 6 months
Secondary Number of missed guideline recommended care opportunities Participants will be followed up for an expected average of 8 years 6 months
See also
  Status Clinical Trial Phase
Completed NCT02600962 - Impact of Initial Diagnosis on Mortality for Patients Hospitalised With Acute Myocardial Infarction N/A
Completed NCT02406248 - Brilinta Taiwan Post Approval Safety Study Phase 4
Completed NCT02693015 - Impact of Time to Coronary Angiography on Survival for NSTEMI N/A